| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 29 | 2022 | 3407 | 2.780 |
Why?
|
| Myocarditis | 17 | 2024 | 788 | 2.450 |
Why?
|
| Lymphocyte Activation | 38 | 2019 | 5485 | 1.710 |
Why?
|
| Cannabinoids | 7 | 2017 | 172 | 1.570 |
Why?
|
| Receptors, Antigen, T-Cell | 19 | 2023 | 2547 | 1.470 |
Why?
|
| Receptors, LDL | 11 | 2016 | 488 | 1.470 |
Why?
|
| T-Lymphocytes | 32 | 2022 | 10194 | 1.450 |
Why?
|
| Th1 Cells | 18 | 2017 | 1036 | 1.390 |
Why?
|
| Receptor, Cannabinoid, CB1 | 5 | 2017 | 137 | 1.340 |
Why?
|
| CD4-Positive T-Lymphocytes | 18 | 2021 | 4369 | 1.240 |
Why?
|
| Interferon-gamma | 15 | 2013 | 3162 | 1.190 |
Why?
|
| Arteriosclerosis | 10 | 2005 | 1055 | 1.130 |
Why?
|
| Aortic Diseases | 3 | 2018 | 735 | 1.070 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 14 | 2018 | 974 | 1.000 |
Why?
|
| Macrophages | 15 | 2018 | 5767 | 0.960 |
Why?
|
| Th2 Cells | 15 | 2016 | 1060 | 0.940 |
Why?
|
| Endothelium, Vascular | 15 | 2014 | 4431 | 0.910 |
Why?
|
| T-Lymphocytes, Cytotoxic | 6 | 2021 | 1784 | 0.900 |
Why?
|
| Piperidines | 9 | 2017 | 1656 | 0.900 |
Why?
|
| T-Lymphocyte Subsets | 13 | 2019 | 1802 | 0.870 |
Why?
|
| Adaptive Immunity | 6 | 2017 | 726 | 0.860 |
Why?
|
| Mice, Knockout | 35 | 2021 | 14417 | 0.780 |
Why?
|
| Monoacylglycerol Lipases | 3 | 2021 | 36 | 0.760 |
Why?
|
| Dendritic Cells | 9 | 2022 | 2747 | 0.750 |
Why?
|
| Lymphocytes | 8 | 2017 | 2612 | 0.730 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2016 | 504 | 0.730 |
Why?
|
| Interleukin-12 | 9 | 2007 | 584 | 0.710 |
Why?
|
| Mice | 98 | 2022 | 81539 | 0.710 |
Why?
|
| Mice, Inbred C57BL | 46 | 2022 | 22174 | 0.700 |
Why?
|
| Inflammation | 23 | 2018 | 10774 | 0.700 |
Why?
|
| CD8-Positive T-Lymphocytes | 15 | 2021 | 4580 | 0.700 |
Why?
|
| E-Selectin | 10 | 2019 | 576 | 0.690 |
Why?
|
| Immunity, Innate | 9 | 2021 | 3066 | 0.690 |
Why?
|
| Animals | 127 | 2024 | 168475 | 0.680 |
Why?
|
| Disease Models, Animal | 22 | 2019 | 18255 | 0.680 |
Why?
|
| Cell Movement | 14 | 2021 | 5205 | 0.670 |
Why?
|
| Interleukin-4 | 15 | 2000 | 1149 | 0.670 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 179 | 0.640 |
Why?
|
| Neutrophils | 8 | 2022 | 3767 | 0.610 |
Why?
|
| Interleukin-2 | 12 | 2015 | 1889 | 0.610 |
Why?
|
| T-Lymphocytes, Regulatory | 11 | 2018 | 3080 | 0.610 |
Why?
|
| P-Selectin | 8 | 2006 | 597 | 0.600 |
Why?
|
| Autoimmune Diseases | 4 | 2020 | 2244 | 0.600 |
Why?
|
| Th17 Cells | 5 | 2020 | 794 | 0.590 |
Why?
|
| Hypercholesterolemia | 5 | 2012 | 1141 | 0.590 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 978 | 0.570 |
Why?
|
| Lipoproteins, LDL | 4 | 2016 | 642 | 0.570 |
Why?
|
| Mice, Transgenic | 24 | 2022 | 9542 | 0.560 |
Why?
|
| Benzodioxoles | 2 | 2015 | 75 | 0.560 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 243 | 0.550 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2013 | 517 | 0.530 |
Why?
|
| Vaccines | 2 | 2023 | 844 | 0.530 |
Why?
|
| Antigens, CD | 7 | 2024 | 4001 | 0.530 |
Why?
|
| Adoptive Transfer | 10 | 2018 | 819 | 0.520 |
Why?
|
| Pyrazoles | 7 | 2017 | 2009 | 0.510 |
Why?
|
| Lipoprotein Lipase | 1 | 2016 | 133 | 0.510 |
Why?
|
| Neutrophil Infiltration | 2 | 2022 | 390 | 0.500 |
Why?
|
| Antigens, Surface | 3 | 2011 | 1606 | 0.500 |
Why?
|
| Membrane Glycoproteins | 9 | 2012 | 3701 | 0.490 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2015 | 306 | 0.480 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2011 | 1136 | 0.450 |
Why?
|
| Blood Platelets | 2 | 2022 | 2479 | 0.440 |
Why?
|
| Cholesterol, Dietary | 2 | 2011 | 224 | 0.440 |
Why?
|
| Analgesics | 3 | 2021 | 1070 | 0.440 |
Why?
|
| Cell Adhesion | 12 | 2016 | 3088 | 0.430 |
Why?
|
| Cytokines | 20 | 2021 | 7396 | 0.430 |
Why?
|
| Amidohydrolases | 3 | 2021 | 159 | 0.430 |
Why?
|
| Autoantibodies | 2 | 2021 | 2118 | 0.430 |
Why?
|
| Enzyme Inhibitors | 4 | 2021 | 3713 | 0.420 |
Why?
|
| Molecular Mimicry | 1 | 2014 | 213 | 0.420 |
Why?
|
| Immunity, Cellular | 4 | 2016 | 1560 | 0.420 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 2014 | 4352 | 0.410 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2021 | 1334 | 0.400 |
Why?
|
| Endothelial Cells | 5 | 2019 | 3549 | 0.400 |
Why?
|
| Antigen-Presenting Cells | 10 | 2015 | 964 | 0.390 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2015 | 625 | 0.390 |
Why?
|
| Cells, Cultured | 25 | 2019 | 18966 | 0.380 |
Why?
|
| Heart | 5 | 2019 | 4404 | 0.380 |
Why?
|
| Cholesterol | 7 | 2013 | 2905 | 0.380 |
Why?
|
| Antigen Presentation | 5 | 2021 | 1251 | 0.380 |
Why?
|
| Diet, Atherogenic | 1 | 2011 | 92 | 0.380 |
Why?
|
| Signal Transduction | 16 | 2019 | 23447 | 0.380 |
Why?
|
| Muscle Cells | 1 | 2012 | 195 | 0.370 |
Why?
|
| Immune Tolerance | 5 | 2015 | 2302 | 0.370 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 347 | 0.370 |
Why?
|
| B-Lymphocytes | 5 | 2021 | 4758 | 0.360 |
Why?
|
| Nitric Oxide | 2 | 2013 | 2136 | 0.350 |
Why?
|
| Cell Proliferation | 8 | 2021 | 10451 | 0.340 |
Why?
|
| Arachidonic Acids | 2 | 2001 | 294 | 0.330 |
Why?
|
| Antibodies | 3 | 2015 | 2418 | 0.330 |
Why?
|
| Neuralgia | 1 | 2016 | 615 | 0.330 |
Why?
|
| Monocytes | 2 | 2017 | 2570 | 0.320 |
Why?
|
| Ovalbumin | 8 | 2018 | 677 | 0.320 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 2417 | 0.320 |
Why?
|
| Arteries | 3 | 2013 | 1123 | 0.320 |
Why?
|
| Peptides | 4 | 2011 | 4358 | 0.310 |
Why?
|
| T-Box Domain Proteins | 4 | 2011 | 469 | 0.310 |
Why?
|
| Receptors, Interferon | 1 | 2007 | 116 | 0.280 |
Why?
|
| Graft Rejection | 6 | 2011 | 4446 | 0.280 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 4 | 2006 | 898 | 0.270 |
Why?
|
| Mice, Inbred BALB C | 15 | 2018 | 6214 | 0.270 |
Why?
|
| Cell Migration Inhibition | 1 | 2006 | 97 | 0.270 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 1809 | 0.260 |
Why?
|
| Behavior, Animal | 4 | 2021 | 1878 | 0.260 |
Why?
|
| Interleukin-17 | 1 | 2012 | 912 | 0.260 |
Why?
|
| Lymph Nodes | 9 | 2021 | 3465 | 0.260 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 7 | 2016 | 691 | 0.250 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2018 | 1532 | 0.250 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 3246 | 0.250 |
Why?
|
| Lipoproteins | 4 | 2017 | 881 | 0.250 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 1924 | 0.250 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2019 | 163 | 0.250 |
Why?
|
| Transcription Factors | 7 | 2014 | 12130 | 0.240 |
Why?
|
| Blood Vessels | 1 | 2010 | 1113 | 0.240 |
Why?
|
| Coculture Techniques | 3 | 2016 | 1341 | 0.230 |
Why?
|
| Receptors, Chemokine | 2 | 2006 | 652 | 0.230 |
Why?
|
| Antigens, Differentiation | 1 | 2007 | 909 | 0.230 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 4878 | 0.230 |
Why?
|
| Aorta | 5 | 2015 | 2041 | 0.220 |
Why?
|
| Flow Cytometry | 9 | 2019 | 5870 | 0.220 |
Why?
|
| Intercellular Adhesion Molecule-1 | 7 | 2019 | 1126 | 0.220 |
Why?
|
| Hyperlipidemias | 2 | 2017 | 771 | 0.210 |
Why?
|
| Models, Immunological | 3 | 2017 | 513 | 0.210 |
Why?
|
| Neuropeptides | 3 | 2018 | 944 | 0.210 |
Why?
|
| Memory | 2 | 2004 | 2193 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 3 | 2016 | 9177 | 0.210 |
Why?
|
| Maze Learning | 2 | 2004 | 483 | 0.210 |
Why?
|
| Cell Adhesion Molecules | 4 | 2015 | 1601 | 0.210 |
Why?
|
| Cell Differentiation | 11 | 2020 | 11530 | 0.210 |
Why?
|
| Sialyltransferases | 1 | 2002 | 83 | 0.200 |
Why?
|
| Immunotherapy | 7 | 2021 | 4652 | 0.200 |
Why?
|
| Myocardium | 7 | 2019 | 4725 | 0.200 |
Why?
|
| Ligands | 4 | 2022 | 3272 | 0.200 |
Why?
|
| Autoantigens | 2 | 2018 | 891 | 0.200 |
Why?
|
| Lymphokines | 5 | 2007 | 927 | 0.200 |
Why?
|
| Opioid Peptides | 1 | 2001 | 37 | 0.190 |
Why?
|
| Morphine Dependence | 1 | 2001 | 27 | 0.190 |
Why?
|
| Leukocytes | 5 | 2019 | 2026 | 0.190 |
Why?
|
| Extinction, Psychological | 1 | 2004 | 371 | 0.190 |
Why?
|
| Space Perception | 1 | 2004 | 465 | 0.190 |
Why?
|
| Transplantation, Homologous | 4 | 2011 | 4807 | 0.190 |
Why?
|
| Cell Communication | 4 | 2022 | 1657 | 0.180 |
Why?
|
| Hallucinogens | 2 | 2001 | 197 | 0.180 |
Why?
|
| Whooping Cough | 1 | 2021 | 86 | 0.180 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2016 | 823 | 0.180 |
Why?
|
| Mice, Inbred ICR | 5 | 2021 | 364 | 0.180 |
Why?
|
| Chaperonin 60 | 4 | 2004 | 97 | 0.180 |
Why?
|
| Complement C3 | 1 | 2002 | 435 | 0.180 |
Why?
|
| Cholates | 1 | 1999 | 4 | 0.170 |
Why?
|
| Receptors, IgG | 2 | 2021 | 559 | 0.170 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 181 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2017 | 10766 | 0.170 |
Why?
|
| Spleen | 5 | 2022 | 2295 | 0.170 |
Why?
|
| Lipid Metabolism | 3 | 2012 | 1902 | 0.170 |
Why?
|
| Narcotics | 1 | 2001 | 336 | 0.160 |
Why?
|
| Mice, Mutant Strains | 4 | 2012 | 1749 | 0.160 |
Why?
|
| Phenotype | 9 | 2018 | 16592 | 0.160 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 1668 | 0.160 |
Why?
|
| Humans | 69 | 2024 | 761596 | 0.160 |
Why?
|
| Measles | 1 | 2021 | 183 | 0.160 |
Why?
|
| Selectins | 1 | 1999 | 101 | 0.160 |
Why?
|
| Apolipoproteins E | 5 | 2018 | 1443 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7859 | 0.160 |
Why?
|
| Gene Expression | 3 | 2010 | 7581 | 0.160 |
Why?
|
| Antigens | 3 | 2022 | 1443 | 0.160 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 2016 | 87 | 0.160 |
Why?
|
| I-kappa B Proteins | 1 | 1999 | 211 | 0.150 |
Why?
|
| Bone Marrow Transplantation | 3 | 2018 | 2693 | 0.150 |
Why?
|
| Interleukin-1 | 4 | 1996 | 1248 | 0.150 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2011 | 662 | 0.150 |
Why?
|
| Chlamydophila Infections | 2 | 2012 | 23 | 0.150 |
Why?
|
| Insect Control | 1 | 2018 | 29 | 0.150 |
Why?
|
| Nephritis | 2 | 2015 | 145 | 0.150 |
Why?
|
| Autoimmunity | 4 | 2019 | 1356 | 0.150 |
Why?
|
| Vasculitis | 2 | 2019 | 521 | 0.150 |
Why?
|
| Pheromones | 1 | 2018 | 93 | 0.150 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2018 | 180 | 0.150 |
Why?
|
| Kirsten murine sarcoma virus | 2 | 1987 | 5 | 0.140 |
Why?
|
| Sarcoma Viruses, Murine | 2 | 1987 | 17 | 0.140 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1787 | 0.140 |
Why?
|
| Hydrolases | 1 | 2018 | 147 | 0.140 |
Why?
|
| Oxidation-Reduction | 3 | 2013 | 2231 | 0.140 |
Why?
|
| Interleukin-10 | 2 | 2022 | 1175 | 0.140 |
Why?
|
| Morphine | 1 | 2001 | 657 | 0.140 |
Why?
|
| Heart Failure | 4 | 2018 | 11671 | 0.140 |
Why?
|
| Foam Cells | 1 | 2017 | 68 | 0.140 |
Why?
|
| Antigens, Neoplasm | 2 | 2021 | 1993 | 0.140 |
Why?
|
| Transcription Factor RelA | 2 | 2014 | 254 | 0.140 |
Why?
|
| Nicotine | 2 | 2015 | 680 | 0.140 |
Why?
|
| Kidney | 4 | 2018 | 7048 | 0.140 |
Why?
|
| Rhabdomyolysis | 1 | 2018 | 152 | 0.140 |
Why?
|
| Heart Transplantation | 3 | 2011 | 3233 | 0.130 |
Why?
|
| Gene Expression Regulation | 11 | 2006 | 11904 | 0.130 |
Why?
|
| Endothelium | 2 | 1997 | 765 | 0.130 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 1410 | 0.130 |
Why?
|
| Cholangiocarcinoma | 1 | 2021 | 552 | 0.130 |
Why?
|
| Trans-Activators | 3 | 2001 | 2856 | 0.130 |
Why?
|
| Egg Proteins | 2 | 2007 | 57 | 0.130 |
Why?
|
| Polysaccharides | 1 | 2002 | 1014 | 0.130 |
Why?
|
| N-Acetylglucosaminyltransferases | 3 | 2002 | 167 | 0.130 |
Why?
|
| Cholesterol, VLDL | 1 | 2015 | 70 | 0.130 |
Why?
|
| Chemokines | 3 | 2016 | 959 | 0.130 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2015 | 57 | 0.130 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2016 | 377 | 0.120 |
Why?
|
| Male | 33 | 2021 | 360846 | 0.120 |
Why?
|
| DNA-Binding Proteins | 8 | 2012 | 9610 | 0.120 |
Why?
|
| Apolipoprotein B-100 | 1 | 2015 | 157 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1092 | 0.120 |
Why?
|
| Interleukin-5 | 1 | 2015 | 269 | 0.120 |
Why?
|
| Mast Cells | 1 | 2022 | 1392 | 0.120 |
Why?
|
| Growth Substances | 2 | 1987 | 768 | 0.120 |
Why?
|
| Platelet Activation | 1 | 2018 | 645 | 0.120 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2014 | 103 | 0.120 |
Why?
|
| Fucosyltransferases | 3 | 2006 | 117 | 0.120 |
Why?
|
| Chlamydophila pneumoniae | 3 | 2012 | 53 | 0.110 |
Why?
|
| Receptors, Cannabinoid | 3 | 2007 | 43 | 0.110 |
Why?
|
| Hypertension | 2 | 2012 | 8540 | 0.110 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1995 | 284 | 0.110 |
Why?
|
| Apolipoproteins B | 1 | 2015 | 386 | 0.110 |
Why?
|
| Granzymes | 1 | 2015 | 277 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 261 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 1 | 1999 | 1036 | 0.110 |
Why?
|
| Receptors, Scavenger | 1 | 2013 | 123 | 0.110 |
Why?
|
| Female | 30 | 2021 | 392705 | 0.110 |
Why?
|
| Cardiac Myosins | 1 | 2013 | 128 | 0.100 |
Why?
|
| Calcium | 7 | 1985 | 5722 | 0.100 |
Why?
|
| NF-kappa B | 4 | 2000 | 2490 | 0.100 |
Why?
|
| CD40 Ligand | 2 | 2008 | 522 | 0.100 |
Why?
|
| RNA, Messenger | 8 | 2015 | 12794 | 0.100 |
Why?
|
| Phagocytosis | 2 | 2016 | 1528 | 0.100 |
Why?
|
| Leukocyte Rolling | 1 | 2012 | 69 | 0.100 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2012 | 110 | 0.100 |
Why?
|
| Lipids | 3 | 2012 | 3341 | 0.100 |
Why?
|
| Calcium-Transporting ATPases | 2 | 1982 | 122 | 0.100 |
Why?
|
| Neoplasms | 5 | 2024 | 22173 | 0.100 |
Why?
|
| Chemokine CCL20 | 1 | 2012 | 64 | 0.100 |
Why?
|
| Lectins, C-Type | 1 | 2015 | 585 | 0.100 |
Why?
|
| Macrophage-1 Antigen | 1 | 2012 | 285 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 1096 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2011 | 2571 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2004 | 1492 | 0.090 |
Why?
|
| Clone Cells | 7 | 1994 | 1659 | 0.090 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2011 | 30 | 0.090 |
Why?
|
| Calgranulin A | 1 | 2011 | 80 | 0.090 |
Why?
|
| Receptors, Drug | 2 | 2001 | 157 | 0.090 |
Why?
|
| Calgranulin B | 1 | 2011 | 86 | 0.090 |
Why?
|
| Serum | 1 | 2012 | 209 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2015 | 2155 | 0.090 |
Why?
|
| Integrin alpha4beta1 | 4 | 2016 | 119 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2017 | 2048 | 0.090 |
Why?
|
| Vascular Neoplasms | 1 | 2012 | 166 | 0.090 |
Why?
|
| Eosinophilia | 1 | 2015 | 560 | 0.090 |
Why?
|
| Endoribonucleases | 1 | 2012 | 228 | 0.090 |
Why?
|
| Kidney Transplantation | 2 | 2015 | 4235 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2017 | 829 | 0.090 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 3076 | 0.090 |
Why?
|
| Antibodies, Blocking | 1 | 2011 | 243 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 1076 | 0.090 |
Why?
|
| Prenylation | 1 | 2010 | 37 | 0.090 |
Why?
|
| Acyl Coenzyme A | 1 | 2010 | 56 | 0.090 |
Why?
|
| Polyunsaturated Alkamides | 2 | 2001 | 29 | 0.090 |
Why?
|
| Immunoglobulins | 2 | 2005 | 852 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 983 | 0.090 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 589 | 0.090 |
Why?
|
| Apoptosis | 3 | 2016 | 9490 | 0.080 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2012 | 290 | 0.080 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2018 | 1351 | 0.080 |
Why?
|
| Thrombophilia | 1 | 2012 | 305 | 0.080 |
Why?
|
| Histone Demethylases | 1 | 2012 | 323 | 0.080 |
Why?
|
| Alphapapillomavirus | 1 | 2012 | 218 | 0.080 |
Why?
|
| Receptors, Lymphocyte Homing | 2 | 2000 | 141 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1999 | 4514 | 0.080 |
Why?
|
| Endocannabinoids | 2 | 2001 | 111 | 0.080 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 606 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 1023 | 0.080 |
Why?
|
| Sodium, Dietary | 1 | 2012 | 425 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15843 | 0.080 |
Why?
|
| Spironolactone | 1 | 2012 | 412 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4576 | 0.080 |
Why?
|
| Immunologic Memory | 3 | 2008 | 1359 | 0.080 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 5799 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 2 | 2000 | 194 | 0.080 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2206 | 0.080 |
Why?
|
| Inflammasomes | 1 | 2013 | 526 | 0.080 |
Why?
|
| Cardiology | 1 | 2019 | 1656 | 0.080 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 17635 | 0.080 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2009 | 318 | 0.070 |
Why?
|
| Cell Line | 10 | 1998 | 15601 | 0.070 |
Why?
|
| Triglycerides | 1 | 2015 | 2461 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1188 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2585 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2019 | 2321 | 0.070 |
Why?
|
| Vas Deferens | 1 | 2007 | 54 | 0.070 |
Why?
|
| TRPV Cation Channels | 1 | 2009 | 244 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 221 | 0.070 |
Why?
|
| Leukemia Virus, Murine | 1 | 1987 | 94 | 0.070 |
Why?
|
| Models, Animal | 2 | 2015 | 2112 | 0.070 |
Why?
|
| Mice, Inbred AKR | 2 | 1999 | 104 | 0.070 |
Why?
|
| Graft Survival | 2 | 2015 | 3820 | 0.070 |
Why?
|
| Calcimycin | 3 | 1983 | 213 | 0.070 |
Why?
|
| Cyclosporine | 3 | 1999 | 778 | 0.070 |
Why?
|
| Clonal Deletion | 1 | 2006 | 74 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 11076 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2418 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2019 | 2781 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 750 | 0.070 |
Why?
|
| Receptors, Leptin | 1 | 2007 | 350 | 0.070 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2012 | 819 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 1 | 2008 | 870 | 0.060 |
Why?
|
| Thrombosis | 2 | 2018 | 2942 | 0.060 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1987 | 357 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 2822 | 0.060 |
Why?
|
| Collagen | 2 | 2012 | 2638 | 0.060 |
Why?
|
| Receptors, CXCR3 | 1 | 2006 | 238 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2014 | 1590 | 0.060 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2005 | 92 | 0.060 |
Why?
|
| Obesity | 1 | 2007 | 12947 | 0.060 |
Why?
|
| Transcription, Genetic | 6 | 2014 | 7593 | 0.060 |
Why?
|
| Lymphocyte Depletion | 1 | 2006 | 602 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 1616 | 0.060 |
Why?
|
| Retroviridae | 1 | 2006 | 850 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1987 | 545 | 0.060 |
Why?
|
| Hemorheology | 2 | 2001 | 144 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2273 | 0.060 |
Why?
|
| Phytohemagglutinins | 2 | 1982 | 167 | 0.060 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2005 | 213 | 0.060 |
Why?
|
| Inflammation Mediators | 2 | 2014 | 1886 | 0.060 |
Why?
|
| Swimming | 1 | 2004 | 208 | 0.060 |
Why?
|
| Drug Design | 1 | 2009 | 1048 | 0.060 |
Why?
|
| Spectrophotometry, Atomic | 3 | 1985 | 82 | 0.050 |
Why?
|
| Lectins | 2 | 1983 | 491 | 0.050 |
Why?
|
| Integrins | 2 | 2000 | 834 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3530 | 0.050 |
Why?
|
| Peanut Agglutinin | 1 | 2002 | 19 | 0.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2021 | 587 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2007 | 5112 | 0.050 |
Why?
|
| Tryptophan Oxygenase | 1 | 2002 | 19 | 0.050 |
Why?
|
| Trifluoperazine | 1 | 1982 | 37 | 0.050 |
Why?
|
| Antigens, Ly | 1 | 2003 | 295 | 0.050 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2006 | 481 | 0.050 |
Why?
|
| Tobacco Use Disorder | 1 | 2008 | 703 | 0.050 |
Why?
|
| Time Factors | 5 | 2017 | 39969 | 0.050 |
Why?
|
| Rubella Vaccine | 1 | 2021 | 23 | 0.050 |
Why?
|
| Mumps Vaccine | 1 | 2021 | 16 | 0.050 |
Why?
|
| Pain Threshold | 2 | 2007 | 604 | 0.050 |
Why?
|
| Carotid Artery Diseases | 2 | 2018 | 877 | 0.050 |
Why?
|
| Kynurenine | 1 | 2002 | 141 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 315 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2006 | 1243 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 908 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 13446 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2004 | 705 | 0.050 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 888 | 0.050 |
Why?
|
| Reward | 1 | 2008 | 971 | 0.050 |
Why?
|
| Ethanolamines | 1 | 2001 | 153 | 0.050 |
Why?
|
| Drug Implants | 1 | 2001 | 230 | 0.050 |
Why?
|
| Base Sequence | 6 | 2005 | 12441 | 0.050 |
Why?
|
| Monokines | 2 | 1999 | 71 | 0.050 |
Why?
|
| Glucose | 1 | 2012 | 4347 | 0.040 |
Why?
|
| Papillomavirus Infections | 1 | 2012 | 1613 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 621 | 0.040 |
Why?
|
| Spatial Behavior | 1 | 2000 | 88 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 8002 | 0.040 |
Why?
|
| Receptors, Opioid, mu | 1 | 2001 | 167 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2003 | 561 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2000 | 116 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2012 | 8481 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2016 | 1835 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2003 | 1968 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2003 | 828 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2021 | 305 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 1 | 2021 | 510 | 0.040 |
Why?
|
| Receptor Aggregation | 1 | 1999 | 72 | 0.040 |
Why?
|
| Muscle, Smooth | 2 | 2018 | 926 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 1999 | 71 | 0.040 |
Why?
|
| Animal Feed | 1 | 1999 | 112 | 0.040 |
Why?
|
| Leptin | 1 | 2007 | 1597 | 0.040 |
Why?
|
| Tyrphostins | 1 | 1999 | 63 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2008 | 2382 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 1996 | 5790 | 0.040 |
Why?
|
| Mucins | 1 | 2022 | 568 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2003 | 1596 | 0.040 |
Why?
|
| Constriction | 1 | 2018 | 168 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2003 | 1173 | 0.040 |
Why?
|
| CHO Cells | 2 | 2000 | 1387 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2000 | 1379 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 1999 | 316 | 0.040 |
Why?
|
| Rheology | 1 | 1999 | 347 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1699 | 0.040 |
Why?
|
| Response Elements | 1 | 1999 | 309 | 0.040 |
Why?
|
| Aerosols | 1 | 2000 | 635 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 1999 | 422 | 0.040 |
Why?
|
| Deoxyribonuclease I | 1 | 2018 | 224 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 779 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2009 | 3826 | 0.040 |
Why?
|
| Brain | 3 | 2014 | 27121 | 0.040 |
Why?
|
| Cricetinae | 2 | 2000 | 2423 | 0.040 |
Why?
|
| Chlamydia trachomatis | 1 | 1999 | 239 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2000 | 1157 | 0.040 |
Why?
|
| Endocytosis | 1 | 2021 | 957 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1986 | 2827 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 4024 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2000 | 553 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 393 | 0.030 |
Why?
|
| Genotype | 1 | 2011 | 12990 | 0.030 |
Why?
|
| Cell Migration Assays, Leukocyte | 1 | 2015 | 8 | 0.030 |
Why?
|
| Kinetics | 5 | 1993 | 6374 | 0.030 |
Why?
|
| Glomerular Basement Membrane | 1 | 2015 | 36 | 0.030 |
Why?
|
| Ionomycin | 1 | 1996 | 110 | 0.030 |
Why?
|
| Tunica Intima | 1 | 2018 | 459 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2000 | 733 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2005 | 1310 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1999 | 636 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 1999 | 560 | 0.030 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2015 | 100 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2019 | 549 | 0.030 |
Why?
|
| Heart Block | 1 | 2016 | 386 | 0.030 |
Why?
|
| Ouabain | 1 | 1975 | 247 | 0.030 |
Why?
|
| SOXF Transcription Factors | 1 | 2014 | 31 | 0.030 |
Why?
|
| Chemokines, CC | 1 | 1996 | 283 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1996 | 817 | 0.030 |
Why?
|
| Diarrhea | 1 | 2001 | 1318 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2015 | 3597 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1996 | 1545 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 1999 | 1869 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2014 | 790 | 0.030 |
Why?
|
| Cytochrome Reductases | 1 | 1973 | 9 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 2018 | 407 | 0.030 |
Why?
|
| Uncoupling Agents | 1 | 1973 | 46 | 0.030 |
Why?
|
| Myositis | 1 | 2016 | 271 | 0.030 |
Why?
|
| Dogs | 1 | 1998 | 3839 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2001 | 4125 | 0.030 |
Why?
|
| Aging | 1 | 2012 | 8710 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 2139 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2003 | 2979 | 0.030 |
Why?
|
| Cell Division | 3 | 1988 | 4465 | 0.030 |
Why?
|
| Protein Binding | 3 | 2014 | 9353 | 0.030 |
Why?
|
| Endosomes | 1 | 2015 | 522 | 0.030 |
Why?
|
| Intradermal Tests | 1 | 2012 | 42 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 802 | 0.030 |
Why?
|
| Cell Death | 1 | 2018 | 1679 | 0.030 |
Why?
|
| Azepines | 1 | 2014 | 329 | 0.030 |
Why?
|
| Skin | 1 | 2006 | 4484 | 0.030 |
Why?
|
| Immunization | 1 | 2016 | 1227 | 0.030 |
Why?
|
| OX40 Ligand | 1 | 2012 | 55 | 0.020 |
Why?
|
| Tumor Necrosis Factors | 1 | 2012 | 107 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6228 | 0.020 |
Why?
|
| Acetylation | 1 | 2014 | 1055 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 2561 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 15502 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11742 | 0.020 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2011 | 93 | 0.020 |
Why?
|
| Biological Transport, Active | 2 | 1982 | 328 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2011 | 509 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2021 | 2911 | 0.020 |
Why?
|
| Disease Progression | 2 | 2018 | 13510 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2011 | 224 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 1993 | 6534 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 613 | 0.020 |
Why?
|
| Eosinophils | 1 | 1996 | 950 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2012 | 214 | 0.020 |
Why?
|
| Potassium | 1 | 1975 | 1311 | 0.020 |
Why?
|
| K562 Cells | 1 | 2012 | 642 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1992 | 562 | 0.020 |
Why?
|
| Histocompatibility | 1 | 2011 | 317 | 0.020 |
Why?
|
| Postprandial Period | 1 | 2012 | 315 | 0.020 |
Why?
|
| Pain | 2 | 2009 | 5073 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3810 | 0.020 |
Why?
|
| Down-Regulation | 1 | 1997 | 2919 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2014 | 539 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 2201 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 421 | 0.020 |
Why?
|
| Axilla | 1 | 2012 | 624 | 0.020 |
Why?
|
| Magnesium | 2 | 1985 | 804 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1991 | 347 | 0.020 |
Why?
|
| Cell Membrane | 4 | 1983 | 3687 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 2425 | 0.020 |
Why?
|
| Carboplatin | 1 | 2012 | 794 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 8181 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1993 | 2467 | 0.020 |
Why?
|
| Triazoles | 1 | 2014 | 903 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2019 | 2639 | 0.020 |
Why?
|
| Body Weight | 1 | 1999 | 4618 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2009 | 9319 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2508 | 0.020 |
Why?
|
| RNA | 2 | 1993 | 2725 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1991 | 799 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1363 | 0.020 |
Why?
|
| Trinitrobenzenes | 1 | 1987 | 46 | 0.020 |
Why?
|
| Dinitrophenols | 2 | 1980 | 56 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2012 | 1642 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2011 | 1435 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1903 | 0.020 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1987 | 68 | 0.020 |
Why?
|
| Middle Aged | 7 | 2021 | 220921 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2016 | 2161 | 0.020 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2007 | 48 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2012 | 707 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1996 | 2910 | 0.020 |
Why?
|
| Cyanides | 2 | 1980 | 82 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1996 | 2448 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 2244 | 0.020 |
Why?
|
| Cyclohexanes | 1 | 2007 | 152 | 0.020 |
Why?
|
| Cyclohexanols | 1 | 2007 | 126 | 0.020 |
Why?
|
| Cisplatin | 1 | 2012 | 1652 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 790 | 0.020 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2012 | 801 | 0.020 |
Why?
|
| Rabbits | 1 | 2012 | 4772 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3878 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2007 | 198 | 0.020 |
Why?
|
| Lymphoma | 1 | 1975 | 1901 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1720 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1996 | 1909 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1987 | 340 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2007 | 1141 | 0.020 |
Why?
|
| Benzoxazines | 1 | 2007 | 316 | 0.020 |
Why?
|
| Echocardiography | 1 | 2017 | 4989 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2012 | 1732 | 0.020 |
Why?
|
| Models, Biological | 1 | 2001 | 9469 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 2915 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 4853 | 0.010 |
Why?
|
| Diet | 2 | 1999 | 8075 | 0.010 |
Why?
|
| Dura Mater | 1 | 1986 | 290 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3597 | 0.010 |
Why?
|
| Locomotion | 1 | 2007 | 388 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 23741 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 6075 | 0.010 |
Why?
|
| Histones | 1 | 2014 | 2580 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1986 | 1762 | 0.010 |
Why?
|
| RNA Interference | 1 | 2012 | 2832 | 0.010 |
Why?
|
| Interleukins | 1 | 1988 | 782 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2009 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 1927 | 0.010 |
Why?
|
| Morpholines | 1 | 2007 | 581 | 0.010 |
Why?
|
| Body Temperature | 1 | 2007 | 781 | 0.010 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2007 | 370 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 7528 | 0.010 |
Why?
|
| Cell Count | 2 | 1979 | 1835 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3430 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2016 | 6377 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1994 | 3032 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6766 | 0.010 |
Why?
|
| Phenols | 1 | 2007 | 517 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6345 | 0.010 |
Why?
|
| Mitogens | 1 | 1983 | 230 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1983 | 337 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 2650 | 0.010 |
Why?
|
| Chromatin | 1 | 2014 | 2961 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 1982 | 199 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1987 | 1395 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1982 | 190 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2007 | 1201 | 0.010 |
Why?
|
| STAT4 Transcription Factor | 1 | 2001 | 93 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2811 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2007 | 1736 | 0.010 |
Why?
|
| Ferric Compounds | 1 | 2003 | 378 | 0.010 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2002 | 117 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 1578 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1981 | 167 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1980 | 7406 | 0.010 |
Why?
|
| Risk Factors | 2 | 2019 | 74213 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 1992 | 364 | 0.010 |
Why?
|
| Carcinoma | 1 | 2012 | 2330 | 0.010 |
Why?
|
| Calmodulin | 1 | 1981 | 218 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 687 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1986 | 897 | 0.010 |
Why?
|
| Ethylene Glycols | 1 | 1981 | 190 | 0.010 |
Why?
|
| Tryptophan | 1 | 2002 | 482 | 0.010 |
Why?
|
| Chlamydia | 1 | 2000 | 33 | 0.010 |
Why?
|
| Cholic Acid | 1 | 1999 | 31 | 0.010 |
Why?
|
| Azides | 1 | 1980 | 118 | 0.010 |
Why?
|
| Particle Size | 1 | 2003 | 1648 | 0.010 |
Why?
|
| Trachea | 1 | 2005 | 1089 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15266 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1981 | 477 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2012 | 3964 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29629 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2002 | 1791 | 0.010 |
Why?
|
| Melanoma | 1 | 2016 | 5709 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2012 | 6391 | 0.010 |
Why?
|
| Nanotechnology | 1 | 2003 | 714 | 0.010 |
Why?
|
| Insulin | 1 | 2012 | 6597 | 0.010 |
Why?
|
| Leishmania major | 1 | 1997 | 59 | 0.010 |
Why?
|
| DNA Replication | 1 | 1985 | 1418 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11120 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23996 | 0.010 |
Why?
|
| Endotoxins | 1 | 2000 | 520 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 12973 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1986 | 1248 | 0.010 |
Why?
|
| Zinc | 1 | 1981 | 690 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 687 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 9420 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2007 | 3551 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1651 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6484 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 1996 | 128 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 36426 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2000 | 1529 | 0.010 |
Why?
|
| Young Adult | 2 | 2012 | 59260 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 1997 | 389 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 10212 | 0.010 |
Why?
|
| Rubidium | 1 | 1975 | 122 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2002 | 1844 | 0.010 |
Why?
|
| Deoxyribonucleoproteins | 1 | 1994 | 3 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1981 | 1989 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 1246 | 0.010 |
Why?
|
| Adult | 3 | 2015 | 221210 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 30053 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1998 | 2264 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1996 | 273 | 0.010 |
Why?
|
| Cholic Acids | 1 | 1973 | 39 | 0.010 |
Why?
|
| Phenylhydrazines | 1 | 1973 | 28 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 1973 | 122 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1975 | 499 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 767 | 0.010 |
Why?
|
| Naphthoquinones | 1 | 1973 | 58 | 0.010 |
Why?
|
| Succinates | 1 | 1973 | 81 | 0.010 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1993 | 67 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1973 | 309 | 0.010 |
Why?
|
| Azacitidine | 1 | 1994 | 336 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1993 | 436 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 1991 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 1973 | 172 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6131 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 169310 | 0.010 |
Why?
|
| Methylation | 1 | 1994 | 1084 | 0.010 |
Why?
|
| Chlorides | 1 | 1994 | 665 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1996 | 2180 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 20568 | 0.010 |
Why?
|
| Genes | 1 | 1994 | 1823 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1998 | 1726 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4174 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1997 | 2665 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1990 | 340 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1993 | 1232 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1994 | 1328 | 0.000 |
Why?
|
| Interleukin-6 | 1 | 1999 | 3208 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 11461 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2012 | 54423 | 0.000 |
Why?
|
| Quinolines | 1 | 1973 | 765 | 0.000 |
Why?
|
| Cattle | 1 | 1973 | 3849 | 0.000 |
Why?
|
| Stroke | 1 | 2009 | 9758 | 0.000 |
Why?
|
| DNA | 1 | 1980 | 7213 | 0.000 |
Why?
|
| Adolescent | 1 | 2012 | 88326 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1982 | 141 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1982 | 297 | 0.000 |
Why?
|
| Colony-Stimulating Factors | 1 | 1982 | 218 | 0.000 |
Why?
|
| Subcellular Fractions | 1 | 1982 | 532 | 0.000 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1982 | 325 | 0.000 |
Why?
|
| Fibrinolysis | 1 | 1982 | 332 | 0.000 |
Why?
|
| Carrier Proteins | 1 | 1994 | 4937 | 0.000 |
Why?
|
| Mathematics | 1 | 1981 | 707 | 0.000 |
Why?
|
| Erythropoiesis | 1 | 1982 | 683 | 0.000 |
Why?
|
| Proteins | 1 | 1982 | 6032 | 0.000 |
Why?
|